Our TRI CEO, Eric Zudak, shares his experience at EADV 2026 (including a mention of his extensive and expanding collection of travel chargers.) See the whole story HERE. One takeaway from EADV was the continued and overwhelmingly enthusiastic response to LAMA: Thalocan’s patented Lesion Area Mapping Assistant, our cloud-based solution for enhancing lesion assessment in…
DetailsOctober: Eczema Awareness Month National Eczema Awareness Month is observed every October to educate the public, reduce stigma, and support the more than 31 million Americans living with eczema. These efforts are led by a number of organizations, including the National Eczema Association and the Asthma and Allergy Foundation of America. Here at Thalocan Research…
DetailsThe Consulting Rainmakers Podcast Thalocan Research Innovations CEO Eric Zudak was recently a guest on the Consulting Rainmakers Podcast hosted by Mikulas Zach. See the full conversation at any of the links below: YouTube: https://youtu.be/gmzhMHOtZkc Apple Podcasts: https://podcasts.apple.com/us/podcast/ai-is-an-aid-to-the-doctor-not-a-replacement-eric-zudak/id6809059223?i=1000790687364 Spotify: https://open.spotify.com/episode/70jRJmKkw758vDSAPCkMMa Here are some of the topics that were discussed: 1. An AI machine can count…
DetailsHeading to EADV! In two weeks, our Thalocan Research Innovations CEO Eric Zudak will be attending the 2026 EADV Congress in Vienna. The congress showcases the latest science, research, and best practices across all areas of dermato-venereology, offering hands-on workshops, sub-specialty sessions, and industry presentations that cover the full spectrum of dermatology and venereology topics.…
DetailsWorld Atopic Eczema Day The European Atopic Eczema Community comes together on World Atopic Eczema Day 2026, September 14th, to amplify the voices of those living with atopic eczema. Atopic eczema is one of the most prevalent skin diseases in the world and one of the most under-recognised. It affects over 230 million people globally, causing chronic pain as well as social, emotional and economic burdens,…
Detailsi-Alfa Training Now Available! Thalocan Research Innovations is proud to announce another collaboration with Dr. Arash Mostaghimi: i-ALFA – Investigator – Alopecia of the Lower Face Assessment – this is our fourth collaboration with Dr. Mostaghimi, the previous being The Severity of Alopecia Tool (SALT), The Brigham Eyebrow Tool for Alopecia (BETA) and the Brigham…
DetailsTwo new trainings on the way! Thalocan Research Innovations is excited to announce that we are in the final stages of post-production on two new expert-led trainings; EASI – The Eczema Area and Severity Index and vIGA-AD – The Validated Investigator Global Assessment for Atopic Dermatitis. Both of these trainings are led by Jonathan…
DetailsAugust is recognized annually as National Psoriasis Awareness Month. Key Facts About Psoriasis:What it is: A chronic autoimmune condition causing the immune system to overreact, speeding up skin cell growth. Appearance: Thick, red patches of skin covered with silvery-white scales that can itch, burn, or sting. Not contagious: It cannot be spread…
DetailsBuilt on Trust, Driven by Innovation A Conversation with Tyler WhiteSenior Director of Business Development, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. Tyler White, Senior Director of Business Development More than Meets the Eye If you picture a business development executive, you probably do not picture someone spending weekends caring for a…
DetailsNOW AVAILABLE on the APP Store and Google Play: The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs,…
Details
